CCR5 and ischemic stroke: These findings show the same profile as seen at the early stage of ischemic stroke (48h post-MCAO), suggesting that at the late stage of ischemic stroke (2 months post-MCAO), brain derived-CCR5, but not the bone marrow-derived CCR5, is critically involved in neuroprotection after focal cerebral ischemia.